> top > docs > PMC:7795856 > spans > 18920-19949 > annotations

PMC:7795856 / 18920-19949 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
324 76-79 Gene denotes Tα1 Gene:50719
325 310-313 Gene denotes Tα1 Gene:50719
326 270-289 Species denotes Sprague–Dawley rats Tax:10116
327 576-582 Species denotes humans Tax:9606
328 991-998 Species denotes patient Tax:9606
329 358-394 Chemical denotes methoxypolyethylene glycol maleimide
330 424-427 Chemical denotes Cys MESH:D003545
331 746-757 Disease denotes hepatitis B MESH:D006509

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T17 738-755 Phenotype denotes chronic hepatitis http://purl.obolibrary.org/obo/HP_0200123

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T109 0-295 Sentence denotes In comparison with other published approaches to prolong the circulation of Tα1, the measured terminal half-life of Tα1-PAS is even longer than the value of around 8.2 h reported for a corresponding PEGylated peptide after an intravenous injection into the tail vein of Sprague–Dawley rats [55].
T110 296-436 Sentence denotes This modified Tα1 was prepared by chemically coupling a 5 kDa methoxypolyethylene glycol maleimide via an engineered N-terminal Cys residue.
T111 437-673 Sentence denotes Of note, according to the rules of allometric scaling, a much longer half-life in the range of several days can be expected for Tα1-PAS in humans [56,57], which would allow weekly dosing while achieving a lasting pharmacological effect.
T112 674-918 Sentence denotes According to the prescription information for Zadaxin™ to treat chronic hepatitis B, the recommended dose for the monotherapy, or the combination therapy with interferon, is a 1.6 mg subcutaneous injection twice weekly over 6 months (52 doses).
T113 919-1029 Sentence denotes Consequently, weekly or biweekly injections would considerably decrease patient burden and improve compliance.